Background: Heat shock proteins (HSPs) are expressed by cells in response to various environmental stresses. A single-nucleotide polymorphism A+1267G of the HSPA1B gene affects the expression of HSP70-2, with the A allele being protective against inflammatory conditions. We investigated the relation between the HSP A+1267G polymorphism and the clinical outcomes of Chinese peritoneal dialysis (PD) patients. Methods: We studied 347 new PD cases (181 males, age 56.6 ± 13.7 years). Genotyping was done by standard methods. Patients were followed for 40.5 ± 20.7 months for survival analysis. Results: For the entire cohort, there was no difference in the 5-year survival between genotype groups. However, there was a significant interaction between HSP polymorphism and diabetic status on the cardiovascular event-free survival. In patients without pre-existing diabetes, 5-year cardiovascular event-free survival of the GG/AG genotype group was significantly better than that of the AA genotype group (57.2 vs. 32.1%, p = 0.011). Conclusion: The G allele of the HSP70-2 A+1267G polymorphism confers survival advantages in non-diabetic PD patients. The role of HSP in the pathogenesis of cardiovascular disease in renal failure patients needs further investigation.

Keywords:
Inflammation, Renal failure, Cardiovascular disease
1.
Yu AWY, Chau KF, Ho YW, Li PKT: Development of the ‘peritoneal dialysis first' model in Hong Kong. Perit Dial Int 2007;27:S53-S55.
2.
Li PKT, Szeto CC: Success of the peritoneal dialysis programme in Hong Kong. Nephrol Dial Transplant 2008;23:1475-1478.
3.
Li PKT, Chow KM: The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients. Perit Dial Int 2005;25:S80-S83.
4.
Krediet RT, Balafa O: Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol 2010;6:451-460.
5.
Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM: C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 2002;62:1417-1422.
6.
Cangemi R, Angelico F, Loffredo L, Del Ben M, Pignatelli P, Martini A, Violi F: Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid. Free Radic Biol Med 2007;43:853-859.
7.
Stephens JW, Bain SC, Humphries SE: Gene-environment interaction and oxidative stress in cardiovascular disease. Atherosclerosis 2008;200:229-238.
8.
Heistad DD, Wakisaka Y, Miller J, Chu Y, Pena-Silva R: Novel aspects of oxidative stress in cardiovascular diseases. Circ J 2009;73:201-207.
9.
Choi HY, Lee JE, Han SH, Yoo TH, Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Lee HY, Han DS: Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients. Nephrol Dial Transplant 2010;25:1266-1271.
10.
Ha H, Yu MR, Lee HB: High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001;59:463-470.
11.
Welten AG, Schalkwijk CG, ter Wee PM, Meijer S, van den Born J, Beelen RJ: Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response. Perit Dial Int 2003;23:213-221.
12.
Inagi R, Miyata T, Yamamoto T, Suzuki D, Urakami K, Saito A, van Ypersele de Strihou C, Kurokawa K: Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 1999;463:260-264.
13.
Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, Danze PM, Dequiedt P: AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 2002;61:148-156.
14.
Feder ME, Hofmann GE: Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu Rev Physiol 1999;61:243-282.
15.
Aufricht C: Heat-shock protein 70: molecular supertool? Pediatr Nephrol 2005;20:707-713.
16.
Meimaridou E, Gooljar SB, Chapple JP: From hatching to dispatching: the multiple cellular roles of the Hsp70 molecular chaperone machinery. J Mol Endocrinol 2009;42:1-9.
17.
Mayer MP: Gymnastics of molecular chaperones. Mol Cell 2010;39:321-331.
18.
Nagata K, Saga S, Yamada KM: A major collagen-binding protein of chick embryo fibroblasts is a novel heat shock protein. J Cell Biol 1986;103:223-229.
19.
Trautinger F, Kindås-Mügge I, Knobler RM, Hönigsmann H: Stress proteins in the cellular response to ultraviolet radiation. J Photochem Photobiol B 1996;35:141-148.
20.
Jonak C, Klosner G, Trautinger F: Significance of heat shock proteins in the skin upon UV exposure. Front Biosci 2009;14:4758-4768.
21.
Jones Q, Voegeli TS, Li G, Chen Y, Currie RW: Heat shock proteins protect against ischemia and inflammation through multiple mechanisms. Inflamm Allergy Drug Targets 2011;10:247-259.
22.
Kalmar B, Greensmith L: Induction of heat shock proteins for protection against oxidative stress. Adv Drug Deliv Rev 2009;61:310-318.
23.
Beyersmann D, Hechtenberg S: Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol Appl Pharmacol 1997;144:247-261.
24.
Razzaque MS, Taguchi T: Involvement of stress proteins in renal diseases. Contrib Nephrol 2005;148:1-7.
25.
Yabunaka N, Ohtsuka Y, Watanabe I, Noro H, Fujisawa H, Agishi Y: Elevated levels of heat-shock protein 70 (HSP70) in the mononuclear cells of patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1995;30:143-147.
26.
Genth-Zotz S, Bolger AP, Kalra PR, von Haehling S, Doehner W, Coats AJ, Volk HD, Anker SD: Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int J Cardiol 2004;96:397-401.
27.
Barutta F, Pinach S, Giunti S, Vittone F, Forbes JM, Chiarle R, Arnstein M, Perin PC, Camussi G, Cooper ME, Gruden G: Heat shock protein expression in diabetic nephropathy. Am J Physiol Renal Physiol 2008;295:F1817-F1824.
28.
Calabrese V, Cornelius C, Leso V, Trovato-Salinaro A, Ventimiglia B, Cavallaro M, Scuto M, Rizza S, Zanoli L, Neri S, Castellino P: Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim Biophys Acta 2012;1822:729-736.
29.
Shioshita K, Miyazaki M, Ozono Y, Abe K, Taura K, Harada T, Koji T, Taguchi T, Kohno S: Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis. Kidney Int 2000;57:619-631.
30.
Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME, Chen B, Hightower LE: Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 2009;14:105-111.
31.
Pociot F, Rønningen KS, Nerup J: Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70-2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand J Immunol 1993;38:491-495.
32.
Lu HQ, Wang YZ, Sun PH, Liang SP, Li J, Wang XL, Xu D, Yao W, Wu YM, Zhou F: Effects of heat shock protein 70-2 gene polymorphisms on the transcription of HSP 70-2 mRNA and the translation of HSP 70 protein in lung cancer. Zhonghua Yu Fang Yi Xue Za Zhi 2012;46:452-455.
33.
Giacconi R, Caruso C, Lio D, Muti E, Cipriano C, Saba V, Boccoli G, Gasparini N, Malavolta M, Mocchegiani E: 1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients. Mech Ageing Dev 2005;126:866-873.
34.
Schroeder S, Reck M, Lehmann LE, Book M, Hoeft A, Stüber F: The Pstl polymorphism of the endotoxin-inducible heat-shock protein 70-2 gene does not affect messenger RNA level in human whole-blood cultures. Intensive Care Med 2000;26:1139-1143.
35.
Esaki M, Furuse M, Matsumoto T, Aoyagi K, Jo Y, Yamagata H, Nakano H, Fujishima M: Polymorphism of heat-shock protein gene HSP70-2 in Crohn disease: possible genetic marker for two forms of Crohn disease. Scand J Gastroenterol 1999;34:703-707.
36.
Klausz G, Molnár T, Nagy F, Gyulai Z, Boda K, Lonovics J, Mándi Y: Polymorphism of the heat-shock protein gene Hsp70-2, but not polymorphisms of the IL-10 and CD14 genes, is associated with the outcome of Crohn's disease. Scand J Gastroenterol 2005;40:1197-1204.
37.
Zouari Bouassida K, Chouchane L, Jellouli K, Chérif S, Haddad S, Gabbouj S, Danguir J: Polymorphism of stress protein HSP70-2 gene in Tunisians: susceptibility implications in type 2 diabetes and obesity. Diabetes Metab 2004;30:175-180.
38.
Balog A, Gyulai Z, Boros LG, Farkas G, Takács T, Lonovics J, Mándi Y: Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas 2005;30:e46-e50.
39.
Buraczynska M, Swatowski A, Buraczynska K, Dragan M, Ksiazek A: Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with type 2 diabetes. Clin Sci (Lond) 2009;116:81-86.
40.
Vargas-Alarcón G, Londoño JD, Hernández-Pacheco G, Gamboa R, Castillo E, Pacheco-Tena C, Cardiel MH, Granados J, Burgos-Vargas R: Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. Ann Rheum Dis 2002;61:48-51.
41.
Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001;38:1251-1263.
42.
Enia G, Sicus C, Alati G, Zoccali C: Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 1993;8:1094-1098.
43.
González-Ramos M, Calleros L, López-Ongil S, Raoch V, Griera M, Rodríguez-Puyol M, de Frutos S, Rodríguez-Puyol D: HSP70 increases extracellular matrix production by human vascular smooth muscle through TGF-β1 up-regulation. Int J Biochem Cell Biol 2013;45:232-242.
44.
Leng X, Wang X, Pang W, Zhan R, Zhang Z, Wang L, Gao X, Qian L: Evidence of a role for both anti-Hsp70 antibody and endothelial surface membrane Hsp70 in atherosclerosis. Cell Stress Chaperones 2013;18:483-493.
45.
Figueredo A, Ibarra JL, Rodriguez A, Molino AM, Gomez-de la Concha E, Fernandez-Cruz A, Patiño R: Increased serum levels of IgA antibodies to hsp70 protein in patients with diabetes mellitus: their relationship with vascular complications. Clin Immunol Immunopathol 1996;79:252-255.
46.
Nakhjavani M, Morteza A, Khajeali L, Esteghamati A, Khalilzadeh O, Asgarani F, Outeiro TF: Increased serum HSP70 levels are associated with the duration of diabetes. Cell Stress Chaperones 2010;15:959-964.
47.
Lo WK: Serum parameters, inflammation, renal function and patient outcome. Contrib Nephrol 2006;150:152-155.
48.
Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008;73:391-398.
49.
De Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW; Netherlands Cooperative Study on the Adequacy of Dialysis-II Study Group: Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 2009;19:127-135.
50.
Leinig CE, Moraes T, Ribeiro S, Riella MC, Olandoski M, Martins C, Pecoits-Filho R: Predictive value of malnutrition markers for mortality in peritoneal dialysis patients. J Ren Nutr 2011;21:176-183.
51.
Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, Kalantar-Zadeh K: Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis 2011;58:418-428.
52.
Kim do K, Lee SM, Son YK, Kim SE, Kim KH, An WS: Factors influencing survival according to elapsed time in peritoneal dialysis patients. Ren Fail 2012;34:559-565.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.